Xenon Pharmaceuticals Inc.(XENE)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
XENE is scheduled to report on Nov 2, 2026, after the market closes. Analysts expect EPS of -$1.16.
EPS: Actual vs Estimate
Reported earnings per share against the consensus estimate, last 12 quarters.
Green = beat or met, red = missed, amber = our data sources disagree on beat vs miss for that quarter.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±4.7%).
Did the stock rise after good news?
"Beat" means the company earned more than analysts expected. Here is what the stock did the next day.
In plain words: it beat expectations 7 times, but the stock still fell 6 of those 7 times.
- Aug '26Beat▼ -1.8%
- May '26Beat▲ +0.8%
- Feb '26Missed▼ -3.8%
- Nov '25Beat▼ -4.9%
- Aug '25Missed▲ +5.5%
- May '25Beat▼ -17.4%
- Nov '24Missed▼ -3.3%
- Aug '24Missed▼ -3.2%
- May '24Beat▼ -4.6%
- Feb '24Beat▼ -0.8%
- Nov '23Beat▼ -6.7%
Only reports with a clear beat or miss and a known price reaction are counted. A beat does not guarantee a gain.
Why did XENE fall after beating earnings?
Beating or missing estimates is only part of the story. These are the measurable things that stand out for each surprising reaction.
XENE beat EPS estimates in 7 quarters, and the stock still closed lower the next day 6 times. In 1 of the 6 where we have price data, the stock had already run up before the report.
- Aug 6, 2026EPS beat +4.3%stock -1.8% next day
- It opened 2.4% lower as soon as trading resumed.
- Nov 3, 2025EPS beat +0.9%stock -4.9% next day
- The EPS beat was small (+0.9%).
- It opened 3.4% lower as soon as trading resumed.
- May 12, 2025EPS beat +7.8%stock -17.4% next day
- It had risen 14.2% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 8.5% lower as soon as trading resumed.
- May 9, 2024EPS beat +4.6%stock -4.6% next day
- It opened 4.1% lower as soon as trading resumed.
- Feb 29, 2024EPS beat +15.8%stock -0.8% next day
- It opened 5.3% higher, but sellers took over and it closed -0.8%.
- Nov 8, 2023EPS beat +2.7%stock -6.7% next day
- It opened 4.0% higher, but sellers took over and it closed -6.7%.
Rose despite an EPS miss (1 of 4)
- Aug 11, 2025EPS missed -8.1%stock +5.5% next day
- It opened 5.5% higher as soon as trading resumed.
These are patterns visible in estimates and prices, not confirmed causes. Information only, not investment advice.
Was XENE's earnings move already priced in?
Stocks often move in the weeks before a report. This compares that run-up with what happened after the report.
“Month before” is the move over the 20 trading days up to the last close before the report. “Priced in” means the good news may already be in the price. A run-up of 5% or more is treated as large.
Before vs after each report
Grey: how the stock moved in the 20 trading days before the report. Green or red: how it moved the day after.
Past reports only: this shows what happened, not what will happen.
Does XENE hold its opening gap after earnings?
A gap is how far the stock opens from the previous close. A gap fades when the stock gives back at least half of it by the end of the day.
In 10 reports XENE opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 10 times (40%), and fully reversed 3 times. Gaps up faded 3 of 4; gaps down recovered 1 of 6.
- Aug 6, 2026HeldOpened -2.4%, closed -1.8%
- Feb 26, 2026ReversedOpened +1.1%, closed -3.8%
- Nov 3, 2025HeldOpened -3.4%, closed -4.9%
- Aug 11, 2025HeldOpened +5.5%, closed +5.5%
- May 12, 2025HeldOpened -8.5%, closed -17.4%
- Feb 27, 2025HeldOpened -3.4%, closed -3.4%
- Aug 8, 2024FadedOpened -10.0%, closed -3.2%
- May 9, 2024HeldOpened -4.1%, closed -4.6%
Gap = opening price vs the previous close. Close = the end of the first session that reflected the report. Reports without a clear opening time are left out.
What the history says
- It fell after 6 of its 7 EPS beats (86%): beating estimates has not been enough on its own.
XENE earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | After close | -$1.16 | -$1.11 | +4.3% | -1.84% | -2.06% |
| May 7, 2026 | After close | -$1.20 | -$1.17 | +2.5% | +0.79% | -1.79% |
| Feb 26, 2026 | After close | -$1.21 | -$1.31 | -8.3% | -3.76% | -2.52% |
| Nov 3, 2025 | After close | -$1.16 | -$1.15 | +0.9% | -4.94% | -6.86% |
| Aug 11, 2025 | After close | -$0.99 | -$1.07 | -8.1% | +5.51% | +11.29% |
| May 12, 2025 | After close | -$0.90 | -$0.83 | +7.8% | -17.43% | -17.52% |
| Feb 27, 2025 | After close | -$0.84 | -$0.84 | 0.0% | -3.37% | -5.98% |
| Nov 12, 2024 | After close | -$0.79 | -$0.81 | -2.5% | -3.27% | -8.20% |
| Aug 8, 2024 | After close | -$0.68 | -$0.75 | -10.3% | -3.19% | -5.39% |
| May 9, 2024 | After close | -$0.65 | -$0.62 | +4.6% | -4.59% | -4.50% |
| Feb 29, 2024 | After close | -$0.76 | -$0.64 | +15.8% | -0.76% | -2.54% |
| Nov 8, 2023 | After close | -$0.75 | -$0.73 | +2.7% | -6.69% | -7.62% |
Consensus for the next report: EPS -$1.16, revenue $0.00.
XENE Earnings FAQ
Answers computed from Xenon Pharmaceuticals Inc.'s reported history
XENE is scheduled to report on Nov 2, 2026, after the market closes. Analysts expect EPS of -$1.16.
Over the last 12 quarters with a usable EPS surprise, XENE beat the consensus estimate 7 times (58%), missed 4 and landed in line 1. It has beaten estimates in each of the last 2 counted quarters.
Across its last 12 quarters with a measured reaction, XENE moved an average of ±4.7% in the first session after reporting. It closed higher 17% of the time; the largest gain was 5.5% and the largest drop -17.4%.
XENE fell in the first session after 6 of its last 7 EPS beats (86%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 1 of the 6 of those falls where price data is available, the stock had already risen before the report.
Across its last 12 quarters with price data, XENE moved an average of +1.0% in the 20 trading sessions before reporting and was higher in 50% of them. After a run-up of 3% or more (6 quarters), it fell the next day 83% of the time, averaging -4.1%. After a drop of 3% or more (4 quarters), it rose the next day 25% of the time, averaging -2.8%. This describes past reports; it is not a forecast.
In 10 reports XENE opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 10 times (40%), and fully reversed 3 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers
Reported EPS and estimates come from Yahoo Finance; report times, upcoming dates and revenue come from Finnhub. The 1-day move is the close-to-close change over the first session that reflects the report (the report-day close for after-close reports, the prior close for pre-market reports); reactions are left blank when the report time is unknown or looks inconsistent. The expected move is the price of the nearest at-the-money straddle that expires after the report divided by the share price, shown only when the quotes are liquid. Quarters where the two data sources disagree on beat versus miss are shown but never counted. Information only, not investment advice.
Looking for more on XENE?
Price charts, forecast, fundamentals and risk pages for XENE are not on Tickzen yet. You can run a full stock analysis now.
Run the XENE Stock Analyzer